BF n = 62/81

non-BF n = 19/81

p

OGTT 0

90.1 ± 16.4

92.2 ± 8.9

0.61

OGTT 30

142.5 ± 34.3

140.1 ± 40.1

0.82

OGTT 60

140.7 ± 42.4

124.0 ± 33.0

0.16

OGTT 90

113.6 ± 36.8

107.0 ± 32.1

0.54

OGTT 120

101.5 ± 28.1

101.2 ± 26.9

0.97

OGTT alteration (%)

DM/IFG/IGT (n˚)

29

7 DM, 5 IFG, 6 IGT

31.6

1 DM, 4 IFG, 1 IFG/IGT

0.34

Homa-IR

2.2 ± 3.9

2.7 ± 2.7

0.64

ISI

8.1 ± 4.2

6.8 ± 3.6

0.34

Homa-IS

1.0 ± 0.7

0.6 ± 0.4

0.04

Insulinogenic index

14.1 ± 14.0

11.7 ± 29.9

0.68

AUCIRI/AUCBG

0.3 ± 0.2

0.4 ± 0.2

0.80

Disposition index

2.5 ± 1.08

1.96 ± 0.62

0.78

Cholesterol (mg/dl)

191.9 ± 37.7

203.4 ± 40

0.31

HDL (mg/dl)

55.9 ± 14.7

55.7 ± 15.4;

0.95

LDL (mg/dl)

116.3 ± 40.7

120.3 ± 29.6

0.76

Triglycerides (mg/dl)

83.8 ± 46.7

123.2 ± 94.0

0.03 Mann-Whitney

ApoA1 (mg/dl)

147.6 ± 22.9

150 ± 37.9

0.79

ApoB (mg/dl)

93.13 ± 25.8

106.8 ± 23.6

0.13

ApoB/ApoA1

0.65 ± 0.23

0.73 ± 0.16

0.31

hs-CRP (mg/L)

0.5 ± 0.7

2.3 ± 6.2

0.08

Homocysteine (µmoli/L)

8.6 ± 3.2

7.9 ± 2.3

0.52

Systolic (mmHg)

112.17 ± 15.7

110 ± 11.9

0.66

Diastolic (mmHg)

71.6 ± 10.6

72.6 ± 9.2

0.73

MS/ATPIII (%)

50.0

27.7

0.67